Skip to main content
OpenTrials

Clinical trial condition

Adnexal Diseases

Explore clinical trials studying Adnexal Diseases. Study availability and eligibility vary by location and protocol.

3,502 public trials 676 recruiting studies
Refine in advanced search Browse all conditions

Adnexal Diseases trial results

Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT06465069

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
View all 38 locations
View Trial Details
Recruiting

Centralization and Oncologic Outcomes in Ovarian Cancer

NCT07075939

Conditions
Adnexal Diseases, Advanced Ovarian Cancer, COVID-19, +30 more
Locations
  • Azienda Unità - Sanitaria locale di Modena - Ospedale Razzini Carpi Carpi, Modena, Italy
  • Azienda Unità - Sanitaria locale di Modena - Ospedale di Mirandola Mirandola, Modena, Italy
  • Azienda Unità - Sanitaria locale di Modena - Ospedale Pavullo nel Frignano Pavullo nel Frignano, Modena, Italy
  • Azienda Unità - Sanitaria locale di Modena - Ospedale Civile Sassuolo Sassuolo, Modena, Italy
View Trial Details
Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT06910657

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +94 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
  • Westmead Hospital Westmead, New South Wales, Australia
View Trial Details
Recruiting

APG-2449 in Patients With Advanced Solid Tumors

NCT03917043

Conditions
Adenoma, Adnexal Diseases, Advanced Solid Cancer, +39 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun-Yat Sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Recruiting

A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine

NCT03854110

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Kansas Cancer Center Fairway, Kansas, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Abramson Cancer Center at the University of Pennsylvania Phildelphia, Pennsylvania, United States
View Trial Details

Related conditions